The European Commission (EC) has issued a draft that seeks to revoke medical device status of proanthocyanidin (PAC)-based cranberry products for treatment and prevention of Urinary Tract Infections (UTI).
from NutraIngredients RSS http://ift.tt/1Pccomn
via IFTTT